openPR Logo
Press release

CDK Websites See Significant Organic Traffic Increases

08-24-2018 09:33 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Reunion Marketing

REUNION MARKETING
Data Beats Intuition
418 S. Dawson St.
Raleigh, North Carolina 27601

NEWS RELEASE
For Immediate Release

CDK Websites See Significant Organic Traffic Increases
The Recent Google Algorithm Affected Traffic Flows Across CMSs

August 20, 2018 — Reunion Marketing personnel noted a remarkable increase in organic traffic for CDK websites that directly coincides with a Google algorithm update.

While conducting regular audits, members of the Reunion team discovered a pattern of significant increases in organic website traffic throughout the month of August compared to July. These numbers prompted an internal audit across Reunion’s entire national dealer network to substantiate the initial finding.

91.7% of CDK sites in Reunion Marketing’s dealership network were affected. These sites saw an average month-over-month increase of 45% in organic traffic. Mobile and tablet devices experienced a more significant share, with the top 20% of dealers achieving 209% and 145% increases respectively.

This change comes on the heels of Google’s “broad core algorithm update” that occurred on August 1, 2018. According to an official statement, Google intended for the update to reward previously undervalued sites, focusing on medical organizations. It is evident, however, that it also affected automotive websites.

CDK was not the only platform to experience a jump in traffic. Others like Dealer.com and DealerOn also had several dealerships with increases ranging from 10-50%; however, the volume of dealerships affected on these other platforms was not as high a percentage and not outside the range of typical results month over month. The Reunion team did not find that any major automotive CMS suffered an overall loss in traffic.

For more information about our findings, please contact our Operations Manager at michael@reunionmarketing.com or visit our website at https://www.reunionmarketing.com/contact.

Reunion Marketing offers a full range of digital marketing services to automotive dealerships and healthcare professionals. Our strategic decisions across all channels are driven by data, including benchmarks from our network of 150+ partners. #DataBeatsIntuition

418 S Dawson St, Raleigh, NC 27601

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CDK Websites See Significant Organic Traffic Increases here

News-ID: 1197960 • Views:

More Releases for CDK

Investigation ongoing for Investors in CDK Global, Inc. (NASDAQ: CDK) over poten …
An investigation on behalf of investors in shares of CDK Global, Inc. (NASDAQ: CDK) was announced over potential breaches of fiduciary duties by certain officers and directors at CDK Global, Inc. Investors who purchased shares of CDK Global, Inc. (NASDAQ: CDK) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain CDK Global, Inc. directors breached
Cancer CDK Inhibitors Market 2021 | Detailed Report
According to Market Study Report, Cancer CDK Inhibitors Market provides a comprehensive analysis of the Cancer CDK Inhibitors Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team. Get Free Sample PDF (including full TOC, Tables and Figures) of Cancer CDK Inhibitors Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5087783 The report provides a
Dealer Management Market Excellent Growth | IBM, CA, Cox Automotive, CDK Global
The qualitative research study conducted by HTF MI titled “Global Dealer Management Market Size, Status and Forecast 2025” provides primary Data, surveys, Scope of the Product and vendor briefings. The market dynamic forces have been determined after conducting a detailed study of the Global Dealer Managementmarket. The study provides forecasts for Dealer Management investments till 2022. If you are involved in the Dealer Management industry or intend to be, then
Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022 Report
“Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022” report highlights: * Selectivity and Working Mechanism of a Cancer CDKs Inhibitor * Recent Advances in the CDKs Related Cancer Therapy * Global Cancer CDK Inhibitors Clinical Trials Insight: 45 Drugs in Pipeline * Market Opportunity Assessment: More Than US$ 20 Billion (2022) * Price Analysis of Cancer CDKs Inhibitors: * Sales Analysis of Available Drugs: More Than US$ 2 Billion (2017) Download Report Sample Weblink:
Download Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022
“Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022” report gives comprehensive insight on clinical and non-clinical parameters related to emergence and growth of CDK inhibitors in cancer therapy. As per report findings, CDK inhibitors have emerged as new growth frontier for the organizations involved in the research, development, licensing and commercialization of targeted cancer therapies. There are 2 CDK inhibitors commercially available in the market for the treatment
Global Cancer CDK Inhibitors Market and Clinical Pipeline Outlook 2022
For Report Sample Contact: neeraj@kuickresearch.com Report Weblink:https://www.kuickresearch.com/report-global-cancer-cdk-inhibitors-market-and-clinical-pipeline-outlook-2022.php Table of Contents 1. Cyclin Dependent Kinase Inhibitors andndash;An Introduction to a Promising Cancer Therapeutic 1.1 History of Discoveries Leading to Cyclin Dependent Kinase Inhibitor Drug 1.2 An Insight into Cell Cycle, Cyclin and the Role of CDKs 1.3 Cyclin Dependent Kinase Inhibitors for Cancer - An Overview 2. Cyclin Dependent Kinase Pathway as Targets for Cancer Therapy 2.1